Obesity Flashcards

1
Q

condition of excess adipose tissue relative to LBM

A

obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how do we identify overweight and obesity?

A

BMI, WC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

health risks of overweight, obesity:

A

CVD, type 2 diabetes, non alcoholic fatty liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

known causes of obesity explain ____% of cases

A

<1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

examples of known causes of obesity:

A

genetic syndromes (Prader-Willi), endocrine (Cushing’s), hypothalamic dysfunction (tumours), medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

meds that cause obesity:

A

glucocorticoids, many psychiatric meds, insulin/thiazolidinediones/sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

genes influence:

A

appetite (leptin), susceptibility to hunger, taste preferences, level of disinhibition, REE (uncoupling proteins), TE of food, nonexercise activity thermogenesis, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

early studies of gene influence vs current:

A

twins and adopted children; obesity gene variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

assessing for risk of chronic disease steps:

A

assess BMI, measure WC, classify for disease risk, combine info with other risk determinants, FPG, lipid profile, liver enzymes, BP, assess for mood disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

major depression and mood disorders occur in ___% of women aged 40+ with BMI > 30 kg/m^2

A

20-60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

common barriers to wt loss?

A

all or nothing mindset, lack of time, loss of motivation, dislike exercise/disability, lack of knowledge, yoyo dieting, low self-efficacy, lack of personal interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 components to lifestyle modification:

A

nutrition, physical activity, CBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

behaviour modification techniques:

A

self monitoring, stimulus control, modify specific eating behaviours and stimuli, reinforcement management, also stress management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

successful wt loss maintenance defined as :

A

> 5% wt loss from baseline maintained 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why is deficit of 500 kcal/day=1-2 lb a week of wt loss a crude estimate?

A

assumes that it will be pound in fat (also losing water, protein structure supporting fat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

obesity class 1 , 2, and 3 BMIs:

A

30-34.9, 35-39.9, 40+

17
Q

disease risk increased for women of WC > __ cm and men WC > ____cm

A

88; 102

18
Q

traditional meds for combating obesity

A

stimulants, orlistat, alternative treatments

19
Q

newer approaches combat obesity:

A

bariatric surgery, brain stimulation (transcranial direct stimulation)

20
Q

safety concerns for stimulants?

A

raise BP and HR

21
Q

this non-stimulant agent inhibits lipases in GI tract, prevents fat breakdown/absorp, minimal systemic absorption

A

orlistat (xenical)

22
Q

orlistat also improves;

A

lipid lvls and BG

23
Q

side effects of orlistat

A

flatus with discharge, oily spotting, fecal urgency, fatty oily stool, fecal incontinence, increased defecation, probs with vit absorption

24
Q

this class of drugs currently under investigation for wt loss, used for diabetes

A

GLP-1 receptor agonists (receptors for incretin hormones–stim insulin secretion; found on beta cells, glucagon-like peptide-1)

25
Q

examples of GLP-1 receptor agonists?

A

liraglutide and exenatide

26
Q

what does liraglutide do?

A

stim insulin secretion, inhibit glucagon release, delay gastric emptying, reduce food intake, normalize fasting and postprandial insulin secretion

27
Q

drug that died out cuz ^ suicides, CV events

A

rimonabant

28
Q

outcomes of taking liraglutide?

A

better HbA1c, reduce FBG, reduce fasting insulin, reduce BP

29
Q

serotonin receptor agonist that affects CNS and reduces appetite

A

locaserin

30
Q

diabetes meds that cause wt gain:

A

insulin, sulfonylureas (glyburide, gliclazide), glitinides (repaglinide, nateglinide)

31
Q

why do some diabetes meds ^ wt?

A

stimulate insulin release which is anabolic

32
Q

why was meridia taken off market?

A

cuz ^ MI

33
Q

to have metabolic syndrome, must have:

A

central obesity >94 and 80 for men and women + 2 of following 4: raised TG, reduced HDL, raised BP, raised FPG